The management of ER low HER2 negative breast cancer in the United Kingdom: A survey of current clinical practice
Loading...
Authors
Contact
Check for full-text access
Issue Date
Type
Conference Proceedings
Language
Keywords
Alternative Title
Abstract
Purpose: There is uncertainty regarding optimal management of ER-low HER2-breast cancer (BC) and whether to treat according to triple negative (TNBC), or ER+ HER2- protocols [1, 2]. We surveyed current approaches of UK breast oncology clinicians in ER-low HER2- BC, and factors influencing their decisions.
Description
Citation
Publisher
License
Journal
Clinical Oncology